Investigating the Role of Immune System in Type 1 Diabetes

Authors

  • Jiantao Su

DOI:

https://doi.org/10.54097/hset.v36i.5786

Keywords:

Type 1 Diabetes, Inflammation, Cytokines.

Abstract

Type 1 diabetes (T1D) refers to the immune system's eradication of the cells that produce insulin in the patients’ islets. Dendritic cells (DCs), macrophages, and lymphocytes are some of the immune cells attended in the relevant immune responses and have been connected to the pathogenesis of T1D. In addition, it is also highlighted that cytokines also activate regulatory processes, like tumor necrosis factor α (TNF-α), interleukin 6 (IL-6) and interleukin 7 (IL-7). It is possible to develop clinical trials for T1D that combine selective cytokine blocking as a component of preventive or interventional immunotherapy. In this project, the current knowledge on the relationship between inflammation and T1D is summarized. Non-specific immune system and specific immune system are highly involved in the complex mechanism and have specific responsibilities respectively. In addition, the roles of different types of cytokines in T1D and cytokine-related potential treatment options are also be discussed in this article.

Downloads

Download data is not yet available.

References

Naushad N, Perdigoto A L, Rui J, et al. Have we pushed the needle for treatment of Type 1 diabetes? [J]. Current opinion in immunology, 2017, 49: 44-50.

DiMeglio L A, Evans-Molina C, Oram R A. Type 1 diabetes[J]. The Lancet, 2018, 391(10138): 2449-2462.

Lu J, Liu J, Li L, et al. Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets[J]. Clinical & translational immunology, 2020, 9(3): e1122.

Merad M, Sathe P, Helft J, et al. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting[J]. Annual review of immunology, 2013, 31.

Jenkins M K, Khoruts A, Ingulli E, et al. In vivo activation of antigen-specific CD4 T cells[J]. Annual review of immunology, 2001, 19(1): 23-45.

Katsarou A, Gudbjörnsdottir S, Rawshani A, et al. Type 1 diabetes mellitus[J]. Nature reviews Disease primers, 2017, 3(1): 1-17.

Steptoe R J, Ritchie J M, Harrison L C. Increased generation of dendritic cells from myeloid progenitors in autoimmune-prone nonobese diabetic mice[J]. The Journal of Immunology, 2002, 168(10): 5032-5041.

MacCuish A C, Jordan J, Campbell C J, et al. Cell-mediated Immunity in Diabetes Mellitus Lymphocyte Transformation by Insulin and Insulin Fragments in Insulin-treated and Newly-diagnosed Diabetics[J]. Diabetes, 1975, 24(1): 36-43.

Smith M J, Simmons K M, Cambier J C. B cells in type 1 diabetes mellitus and diabetic kidney disease[J]. Nature Reviews Nephrology, 2017, 13(11): 712-720.

Jones S A, Jenkins B J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer[J]. Nature Reviews Immunology, 2018, 18(12): 773-789.

Downloads

Published

21-03-2023